Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0E9NT
|
||||
| Former ID |
DNC007142
|
||||
| Drug Name |
2,3,4-trihydroxybenzoic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C7H6O5
|
||||
| Canonical SMILES |
C1=CC(=C(C(=C1C(=O)O)O)O)O
|
||||
| InChI |
1S/C7H6O5/c8-4-2-1-3(7(11)12)5(9)6(4)10/h1-2,8-10H,(H,11,12)
|
||||
| InChIKey |
BRRSNXCXLSVPFC-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | L-selectin | Target Info | Inhibitor | [1] | |
| P-selectin | Target Info | Inhibitor | [1] | ||
| KEGG Pathway | Cell adhesion molecules (CAMs)hsa04514:Cell adhesion molecules (CAMs) | ||||
| Malaria | |||||
| Staphylococcus aureus infection | |||||
| NetPath Pathway | IL9 Signaling Pathway | ||||
| IL2 Signaling Pathway | |||||
| Leptin Signaling Pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| amb2 Integrin signaling | |||||
| Reactome | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | ||||
| Cell surface interactions at the vascular wallR-HSA-114608:Platelet degranulation | |||||
| Cell surface interactions at the vascular wall | |||||
| WikiPathways | Human Complement System | ||||
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | |||||
| Cell surface interactions at the vascular wallWP2806:Human Complement System | |||||
| Spinal Cord Injury | |||||
| Cell surface interactions at the vascular wall | |||||
| References | |||||
| REF 1 | J Med Chem. 2007 Mar 22;50(6):1101-15. Epub 2007 Feb 16.Rational design of novel, potent small molecule pan-selectin antagonists. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.